Blood Pressure Pharmacology Plaque 
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. For cardiovascular disease, only low-density lipoprotein cholesterol and blood pressure are approved as surrogates for cardiovascular disease.
DAIC
FEBRUARY 29, 2024
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Dr. Paddy Barrett
APRIL 5, 2024
Primary prevention is the management of the risk factors, e.g. high blood pressure, early in life to prevent complications of the condition, i.e. coronary artery disease. Blood Pressure Control High blood pressure is the risk factor associated with the greatest number of deaths worldwide. N Engl J Med.
DAIC
MAY 16, 2024
PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life.
DAIC
JANUARY 23, 2024
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 4 In the U.S. 2015.06.013 31.
Expert insights. Personalized for you.
59 
Let's personalize your content